Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab

Autor:	Ramagopal, Udupi A., Liu, Weifeng, Garrett-Thomson, Sarah C., Bonanno, Jeffrey B., Yan, Qingrong, Srinivasan, Mohan, Wong, Susan C., Bell, Alasdair, Mankikar, Shilpa, Rangan, Vangipuram S., Deshpande, Shrikant, Korman, Alan J., Almo, Steven C.
Zdroj:	Proceedings of the National Academy of Sciences of the United States of America, 2017 May . 114(21), E4223-E4232.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26483333 Zobrazit plný text záznamu